Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- A ...

Another observational study has questioned whether Impella ventricular assist pumps (Abiomed) should be used in patients with acute myocardial infarction (MI) complicated by cardiogenic shock (CS), at ...

Use of the Impella percutaneous left ventricular assist device (Abiomed) in acute MI complicated by cardiogenic shock (AMICS) in the United States increased nearly fivefold between 2012 and 2017, a ...

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) is committed to improving patient outcomes by performing FDA studies and post-market surveillance, collecting real-world evidence and ...

DANVERS, Mass., May 18, 2023 – Abiomed, part of Johnson & Johnson MedTech [1], announces results of a third-party analysis showing that utilizing Impella during high-risk percutaneous coronary ...

PHILADELPHIA, PA—Two large observational studies are casting doubt on how well newer forms of mechanical circulatory support (MCS) are performing in real-world practice in the United States. The ...

As physicians increasingly treat patients with more complex CAD, the use of hemodynamic support in the cath lab may become commonplace. However, the availability of multiple systems, including the ...

April 3, 2011 (New Orleans, Louisiana) — Even though the PROTECT II trial of the Impella 2.5 circulatory assist device (Abiomed, Danvers, MA) was stopped early for futility, the trial's lead ...

The use of left-sided Impella microaxial flow pumps has expanded rapidly for the management of cardiogenic shock, left ...

In a cohort of patients who underwent high-risk PCI, mechanical circulatory support with a microaxial blood pump was linked to lower odds of death, MI and cardiogenic shock compared with use of an ...

The data source has significant limitations, containing just a fraction of Impella patients and unable to delineate between common adverse events The Impella patients were much sicker and had greater ...